Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$582M |
| 2 |
Robinhood
HOOD
|
+$430M |
| 3 |
Roku
ROKU
|
+$350M |
| 4 |
Teladoc Health
TDOC
|
+$294M |
| 5 |
Twilio
TWLO
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.04B |
| 2 |
Zillow
Z
|
+$739M |
| 3 |
Unity
U
|
+$634M |
| 4 |
Coinbase
COIN
|
+$448M |
| 5 |
Shopify
SHOP
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.87% |
| 2 | Technology | 31.26% |
| 3 | Communication Services | 12.85% |
| 4 | Consumer Discretionary | 9.99% |
| 5 | Financials | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Similarweb
SMWB
$727M
| $2.74M | 0.01% |
152,868
-2,844
| -2% | -$52.2K |
|
177
CollPlant Biotechnologies
CLGN
$5.91M
| $2.71M | 0.01% |
165,454
-25,836
| -14% | -$461K |
|
|
NTBL
178
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $2.62M | 0.01% |
38,006
-1,807
| -5% | -$139K |
|
|
PPBT
179
Purple Biotech
PPBT
$2.55M
| $2.58M | 0.01% |
3,312
-368
| -10% | -$313K |
|
180
InMode
INMD
$867M
| $2.57M | 0.01% |
36,457
-101,743
| -74% | -$8.16M |
|
181
JFrog
FROG
$11.4B
| $2.54M | 0.01% |
85,514
+4,439
| +5% | +$146K |
|
182
Gilat Satellite Networks
GILT
$809M
| $2.53M | 0.01% |
358,058
-26,217
| -7% | -$205K |
|
|
WKME
183
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $2.48M | 0.01% |
126,192
+7,856
| +7% | +$176K |
|
|
TARO
184
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $2.47M | 0.01% |
49,259
-1,908
| -4% | -$107K |
|
185
WIX.com
WIX
$3.43B
| $2.47M | 0.01% |
15,633
+3,259
| +26% | +$565K |
|
186
Allot
ALLT
$366M
| $2.45M | 0.01% |
206,051
+11,286
| +6% | +$148K |
|
187
Teva Pharmaceuticals
TEVA
$43.5B
| $2.44M | 0.01% |
304,792
-99,204
| -25% | -$895K |
|
188
PolyPid
PYPD
$104M
| $2.33M | 0.01% |
13,552
-2,162
| -14% | -$456K |
|
189
Ceragon Networks
CRNT
$191M
| $2.33M | 0.01% |
904,394
-124,418
| -12% | -$375K |
|
190
Cognyte Software
CGNT
$636M
| $2.23M | 0.01% |
142,013
-2,079
| -1% | -$42K |
|
|
MBAI
191
Check-Cap
MBAI
$11.1M
| $2.2M | 0.01% |
23,270
+1,481
| +7% | +$174K |
|
192
Enlivex Ltd
ENLV
$25.7M
| $2.18M | 0.01% |
23,287
-7,233
| -24% | -$852K |
|
|
BLRX
193
BioLineRX
BLRX
$12.3M
| $2.16M | 0.01% |
26,493
-355
| -1% | -$37K |
|
194
Fiverr
FVRR
$331M
| $2.02M | 0.01% |
17,784
+896
| +5% | +$140K |
|
195
MediWound
MDWD
$171M
| $1.97M | 0.01% |
119,167
+9,899
| +9% | +$206K |
|
196
Entera Bio
ENTX
$559M
| $1.95M | 0.01% |
690,922
+7,915
| +1% | +$29.7K |
|
|
GMDA
197
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $1.91M | 0.01% |
751,069
+127,395
| +20% | +$420K |
|
198
Nano X Imaging
NNOX
$67.6M
| $1.89M | 0.01% |
129,903
+6,290
| +5% | +$130K |
|
199
Playtika
PLTK
$904M
| $1.87M | 0.01% |
108,001
-47,505
| -31% | -$1.06M |
|
|
CMMB
200
Chemomab Therapeutics
CMMB
$15.8M
| $1.84M | 0.01% |
66,823
+21,692
| +48% | +$770K |
|
Similar funds
Cathie Wood's Q4 2021 Portfolio in Review
As of Q4 2021, Cathie Wood held 374 positions worth $33.1B, down 21% from $41.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Cathie Wood withdrew a net $3.12B in Q4 2021, closing 12 positions and reducing 191 holdings. Its most notable exit was GeneDx Holdings, an estimated $71.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Cathie Wood opened a new position in Nu Holdings worth $36.8M.
- Cathie Wood's largest Q4 2021 buy was Nu Holdings: 3,928,467 shares worth $36.8M.
- Cathie Wood added most to Zoom in Q4 2021, an estimated $582M increase.
- Cathie Wood's biggest Q4 2021 reduction was Tesla, cutting an estimated $2.04B.
- Cathie Wood fully exited GeneDx Holdings in Q4 2021, selling an estimated $71.3M.
- Cathie Wood's ten largest holdings make up 40% of its $33.1B portfolio in Q4 2021.
- Cathie Wood opened 75 new positions and closed 12 in Q4 2021.
- Cathie Wood's portfolio value fell 21% quarter-over-quarter to $33.1B.
Based on ARK Investment Management's 13F filing for Q4 2021, filed 28 Jan 2022.